4 This study did not examine duration of GLP-1 use, dosage, nor time from starting GLP-1 use to the breast imaging
View Study Ohara H, Matsumoto H, Ito K, et al
The 3-dimensional structures of GCGR, GLP-1R and GIPR solved previously helped us better understand the molecular basis of ligand recognition and receptor activation of these important class B1 GPCRs 25,32,44,45,46
The new label includes references to some of those postmarketing risks, including intestinal obstruction, [and] severe constipation including fecal impaction. Some patients who took Zepbound have filed lawsuits, accusing Eli Lilly of failing to properly warn them that Zepbound could increase their risk of severe gut problems, including bowel obstructions, pancreatitis, and gastroparesis
Current community protocols typically use 50-100mg taken orally once daily, but these are not clinically validated